JP2024536869A5 - - Google Patents

Info

Publication number
JP2024536869A5
JP2024536869A5 JP2024518884A JP2024518884A JP2024536869A5 JP 2024536869 A5 JP2024536869 A5 JP 2024536869A5 JP 2024518884 A JP2024518884 A JP 2024518884A JP 2024518884 A JP2024518884 A JP 2024518884A JP 2024536869 A5 JP2024536869 A5 JP 2024536869A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
pharmaceutically acceptable
unsubstituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536869A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077001 external-priority patent/WO2023049887A1/en
Publication of JP2024536869A publication Critical patent/JP2024536869A/ja
Publication of JP2024536869A5 publication Critical patent/JP2024536869A5/ja
Pending legal-status Critical Current

Links

JP2024518884A 2021-09-27 2022-09-26 イミダゾピリダジンil-17阻害剤化合物 Pending JP2024536869A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163248566P 2021-09-27 2021-09-27
US63/248,566 2021-09-27
US202163273422P 2021-10-29 2021-10-29
US63/273,422 2021-10-29
US202263367546P 2022-07-01 2022-07-01
US63/367,546 2022-07-01
PCT/US2022/077001 WO2023049887A1 (en) 2021-09-27 2022-09-26 Imidazopyridazine il-17 inhibitor compounds

Publications (2)

Publication Number Publication Date
JP2024536869A JP2024536869A (ja) 2024-10-08
JP2024536869A5 true JP2024536869A5 (cg-RX-API-DMAC7.html) 2025-09-19

Family

ID=83692741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518884A Pending JP2024536869A (ja) 2021-09-27 2022-09-26 イミダゾピリダジンil-17阻害剤化合物

Country Status (16)

Country Link
US (2) US12173007B2 (cg-RX-API-DMAC7.html)
EP (1) EP4408847A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536869A (cg-RX-API-DMAC7.html)
KR (1) KR20240082369A (cg-RX-API-DMAC7.html)
AU (1) AU2022349687A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233408A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024000867A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024003723A2 (cg-RX-API-DMAC7.html)
DO (1) DOP2024000051A (cg-RX-API-DMAC7.html)
IL (1) IL311751A (cg-RX-API-DMAC7.html)
JO (1) JOP20240059A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024003772A (cg-RX-API-DMAC7.html)
PE (1) PE20240935A1 (cg-RX-API-DMAC7.html)
TW (1) TW202330530A (cg-RX-API-DMAC7.html)
UY (1) UY39958A (cg-RX-API-DMAC7.html)
WO (1) WO2023049887A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022349687A1 (en) 2021-09-27 2024-05-16 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
US12024507B2 (en) 2021-10-25 2024-07-02 Terns Pharmaceuticals, Inc. Compounds as GLP-1R agonists
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
AU2024213283A1 (en) * 2023-01-30 2025-08-14 Dice Alpha, Inc. Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
EP4688156A1 (en) * 2023-03-28 2026-02-11 Janssen Pharmaceutica NV Lactam-containing imidazopyridazine il-17 inhibitor compounds
PE20252787A1 (es) 2023-04-07 2025-12-22 Terns Pharmaceuticals Inc Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica
WO2024215597A1 (en) * 2023-04-11 2024-10-17 Dice Alpha, Inc. Substituted 6-imidazopyridazine il-17a modulators and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111601799B (zh) * 2018-01-15 2023-06-09 Ucb生物制药有限责任公司 作为Il-17调节剂的稠合咪唑衍生物
TWI752400B (zh) * 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
CN112341450B (zh) * 2019-08-09 2022-05-17 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021098844A1 (zh) * 2019-11-20 2021-05-27 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021170627A1 (en) * 2020-02-25 2021-09-02 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
JP7664947B2 (ja) 2020-04-30 2025-04-18 ヤンセン ファーマシューティカ エヌ.ベー. Il-17の調節因子としてのイミダゾリダジン
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
AU2022349687A1 (en) 2021-09-27 2024-05-16 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
CN116143777A (zh) 2021-11-04 2023-05-23 四川海思科制药有限公司 一种可抑制il-17a的杂环化合物及其用途

Similar Documents

Publication Publication Date Title
JP2024536863A5 (cg-RX-API-DMAC7.html)
JP2023524018A5 (cg-RX-API-DMAC7.html)
JP7641388B2 (ja) 一連のピペリジン置換安息香酸系化合物及びその使用
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2024536862A5 (cg-RX-API-DMAC7.html)
JP2023523770A5 (cg-RX-API-DMAC7.html)
JP2024100974A5 (cg-RX-API-DMAC7.html)
JP2022519636A5 (cg-RX-API-DMAC7.html)
JP2024178191A5 (cg-RX-API-DMAC7.html)
JP2024536868A5 (cg-RX-API-DMAC7.html)
JP2818820B2 (ja) 抗炎症剤としての3−アリール−2−イソオキサゾリン類
HRP20100020T1 (hr) Novi derivati hidantoina za liječenje opstruktivnih bolesti dišnih putova
JP2012521994A5 (cg-RX-API-DMAC7.html)
JP2022544714A5 (cg-RX-API-DMAC7.html)
JP2017518959A5 (cg-RX-API-DMAC7.html)
JP2023515617A5 (cg-RX-API-DMAC7.html)
JP2018519302A5 (cg-RX-API-DMAC7.html)
JP2021535174A5 (cg-RX-API-DMAC7.html)
JP2018519323A5 (cg-RX-API-DMAC7.html)
JP2014530900A5 (cg-RX-API-DMAC7.html)
JP2008505171A5 (cg-RX-API-DMAC7.html)
JP2009534406A5 (cg-RX-API-DMAC7.html)
EP2044023A1 (en) Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
JP2021535177A5 (cg-RX-API-DMAC7.html)
JP2016147858A5 (cg-RX-API-DMAC7.html)